| |
 |
| AACI
2004 Annual Meeting/CCAF Fall 2004 Meeting
More
than 200 cancer center directors and administrative
leaders from AACI member institutions convened
October 24-26 at The Peninsula Chicago for the
Association’s 2004 annual meeting. AACI
combined the meeting again this year with the
fall 2004 meeting of the Cancer Center Administrators
Forum (CCAF).
The
proceedings of the meeting will be distributed
to attendees and posted on the AACI website soon,
including speakers’ handouts. Photos and
highlights of the meeting will be featured in
the November issue of AACI Update.
To
all who attended, thanks for joining AACI and
the CCAF in Chicago and contributing to a great
meeting! |
|
 |
| University
of Illinois at Chicago Cancer Center Joins AACI
AACI
is pleased to announce that the University of
Illinois at Chicago (UIC) Cancer Center is the
newest member of the association. Ronald Hoffman,
M.D., directs the emerging center in Chicago,
Ill, that was established in 2000 to develop and
coordinate programs, resources and services that
will help UIC achieve cancer center status from
NCI.
The
UIC Cancer Center is a matrix center that reports
to UIC’s dean of the College of Medicine
and to the Health Sciences Deans’ Council. The
Cancer Center is associated with Mount Sinai Medical
Center, Stroger Hospital of Cook County, and the
Veterans Administration West Side Medical Center.
The
Cancer Center’s principal basic science activities
include thematic research programs in carcinogenesis
and chemoprevention; hematopoiesis and leukemia;
molecular targets and developmental therapeutics
in womens’ cancers; oral cancer biology, prevention
& treatment; prevention and tumor biology
of colon and hepatocellular carcinoma. UIC’s cancer
control research activities include early detection
and population science; quality of life and supportive
care; and tobacco use prevention and cessation.
AACI
welcomes the UIC Cancer Center! |
|
|
| Retired
Fox Chase Cancer Center Scientist Shares 2004
Nobel Prize in Chemistry
Dr. Irwin A.
Rose
Retired
Fox Chase Cancer Center scientist Irwin A. Rose,
Ph.D., will share the 2004 Nobel Prize in chemistry
with two Israeli colleagues, Aaron Ciechanover,
Ph.D., and Avram Hershko, Ph.D., for a series
of biochemical studies on the breakdown of proteins
within cells. Starting in the late 1970s,
much of their joint work was done during a series
of sabbatical leaves that Dr. Hershko and Dr.
Ciechanover spent as visiting scientists in Dr.
Rose’s laboratory at Fox Chase Cancer Center in
Philadelphia. Dr. Hershko and Dr. Ciechanover
are both scientists at Technion-Israel Institute
of Technology in Haifa.
A
senior member of Fox Chase Cancer Center’s Division
of Basic Science since 1963, Dr. Rose was elected
to the National Academy of Sciences in 1979.
He retired from Fox Chase in 1995. In 1997,
he accepted a special appointment as emeritus
researcher at the University of California at
Irvine, where he continues to have research responsibilities.
Before joining Fox Chase, Dr. Rose served on the
faculty of Yale Medical School’s department of
biochemistry from 1954 to 1963.
The focus
of the Nobel Prize-winning research is the regulatory
protein ubiquitin—so named because it is ubiquitous
in the cells of animals and plants. Ubiquitin
serves as each cell’s internal garbage disposal,
using an enzyme system to target unwanted proteins
for breakdown and recycling once their specific
task within the cell is done. The ubiquitin
system has become a target for drug development,
either to prevent destruction of critical proteins
or to destroy unwanted ones. One drug is
in clinical trials for the treatment of multiple
myeloma. More
> |
|
|
| News
from the Centers
 |
Dana-Farber
Cancer Institute Dana-Farber
Cancer Institute has recruited Saul Weingart,
M.D., Ph.D., a national expert on medical
error prevention, to be vice president for
patient safety and the director of the Center
for Patient Safety. Dr. Weingart, who comes
to Dana-Farber from Beth Israel Deaconess
Medical Center in Boston, combines the experience
of being a practicing physician with an
extensive background in the research, teaching
and administration of medical error prevention
initiatives. More
> |
Holden
Comprehensive Cancer Center
Larry
Oberley, Ph.D., professor of radiation oncology
in the University of Iowa Roy J. and Lucille A.
Carver College of Medicine, will receive the first
Lifetime Achievement Award from the Society for
Free Radical Biology and Medicine (SFRBM).
Dr. Oberly is deputy director of the Holden Comprehensive
Cancer Center. More
>
Kimmel
Cancer Center
Renato Baserga, M.D., has been named the interim
director of the Kimmel Cancer Center of Thomas
Jefferson University and Thomas Jefferson University
Hospital. Dr. Baserga, deputy director of the
Kimmel Cancer Center, is an internationally recognized
leader in research in basic mechanisms of cancer
cell biology. More
>
Ohio
State University Comprehensive Cancer Center
A
team of scientists in the Ohio State University
Comprehensive Cancer Center – Arthur G. James
Cancer Hospital and Richard J. Solove Research
Institute will receive $7.4 million from the National
Cancer Institute (NCI) to study two key chemical
and structural changes throughout the human genome
that appear to be linked to the growth and development
of many types of cancer. More
>
Siteman
Cancer Center
Timothy
J. Eberlein, M.D., director of the Siteman Cancer
Center at Barnes-Jewish Hospital and Washington
University School of Medicine, has been elected
to the National Academy of Sciences’ Institute
of Medicine, one of the highest honors medical
scientists in the United States can receive. Dr.
Eberlein was selected in recognition of his professional
achievements in medical science and health care
and leadership in issues affecting public health.
More
>
 Vanderbilt-Ingram
Cancer Center
Experienced
health educator Tonya H. Micah has joined the
Vanderbilt-Ingram Cancer Center to lead cancer
prevention, education and awareness initiatives
targeting African-American and other “underserved”
groups in Middle Tennessee. In the newly
created position of minority outreach manager,
Ms. Micah will be responsible for building and
nurturing relationships in the community, developing
and implementing programs designed to address
differences in cancer mortality and morbidity,
and increasing interest in clinical trials. More
>
UCSF
Comprehensive Cancer Center
Three program members of the UCSF Comprehensive
Cancer Center have been elected to the Institute
of Medicine of the National Academies, considered
one of the highest honors in the fields of medicine
and health. Election recognizes major contributions
to medical sciences, health care and public health.
New members are Fred E. Cohen M.D.; Shaun R. Coughlin,
M.D., Ph.D., and Arthur Weiss, M.D., Ph.D.
More
> |
|
|
| Funding
Opportunities
The
Lance Armstrong Foundation Survivorship Fellow
Program
Deadline: November 15,
2004 (Graduate Fellow)
The
Lance Armstrong Foundation (LAF) Survivorship
Fellows Program provides an opportunity to learn
about and become involved in cancer survivorship
and LAF programs. Fellows will gain experience
working in the cancer community and learning about
the issues at the forefront of cancer survivorship.
LAF Fellows will work in the survivorship department
to improve current programs and develop new initiatives
in the foundation’s four programmatic areas: advocacy,
education, public health, and research. Specific
project assignments will depend on the Fellow's
education and interests.
Number
of positions
One
graduate fellowship is available from January
2005 - December 2005. (One
undergraduate fellowship is also available each
year.)
Description
The
graduate fellowship provides a yearlong introduction
to LAF programs and the cancer community.
Fellows have the opportunity to:
-
Work
with advocacy, education, public health, and
research staff
-
Work
on individual projects tailored to their interests
-
Represent
LAF at partnership events or meetings
-
Attend
at least one professional meeting or conference
Examples
of projects for Fellows with a graduate degree:
-
Work
with public health staff to create a training
program for community survivorship advocates
-
Analyze
effectiveness of programs that the LAF funds
through the Community and Research Programs
-
Develop
a plan for outreach to underserved and rural
populations
-
Create
a continuing survivorship education class
for oncologists
Requirements
Participants
must meet the following criteria:
-
Recent
graduate (within past two years) with Master’s
or other advanced degree
-
Be
a cancer survivor or survivor advocate
-
Interested
in a career in healthcare, public health,
health advocacy, or a related field
-
Extremely
motivated to help the cancer community
-
Have
good oral communication and writing skills
Compensation
LAF
Fellows are salaried positions with full benefits.
Salary is based on the level of education and
experience.
How
to apply
The
deadline for graduate applicants to submit applications
for the 2005 Survivorship Fellows Program is November
15, 2004. For additional information and
to obtain an application, visit the LAF Web site
at www.laf.org
or contact Daniela del Castillo, Associate Director
of Volunteer Services at (512) 236-8820 or daniela.delcastillo@laf.org.
The Lance Armstrong Foundation Survivorship
Fellow Program
Deadline: March 15, 2005
(Undergraduate Fellow)
The
Lance Armstrong Foundation (LAF) Survivorship
Fellows Program provides an opportunity to learn
about and become involved in cancer survivorship
and LAF programs. Fellows will gain experience
working in the cancer community and learning about
the issues at the forefront of cancer survivorship.
LAF Fellows will work in the survivorship department
to improve current programs and develop new initiatives
in the foundation’s four programmatic areas: advocacy,
education, public health, and research. Specific
project assignments will depend on the Fellow's
education and interests.
One
undergraduate fellowship is available from June
2005 - May 2006. (One
graduate fellowship is also available each year.)
The
undergraduate fellowship provides a yearlong introduction
to LAF programs and the cancer community.
Fellows have the opportunity to:
-
Work
with advocacy, education, public health, and
research staff
-
Work
on individual projects tailored to their interests
-
Represent
LAF at partnership events or meetings
-
Attend
at least one professional meeting or conference
Examples
of projects for Fellows with an undergraduate
degree:
-
Work
with public health staff to coordinate meetings
of Community Program partners
-
Assist
advocacy staff in increasing grassroots outreach
efforts
-
Develop
a distribution plan for LAF education materials
-
Create
a publication highlighting the LAF Research
Program
Requirements
Participants
must meet the following criteria:
-
Recent
graduate (within past two years) with bachelor's
degree
-
Be
a cancer survivor or survivor advocate
-
Interested
in a career in healthcare, public health,
health advocacy, or a related field
-
Extremely
motivated to help the cancer community
-
Have
good oral communication and writing skills
Compensation
LAF
Fellows are salaried positions with full benefits.
Salary is based on the level of education and
experience.
How
to apply
The
deadline for graduate applicants to submit applications
for the 2005 Survivorship Fellows Program is March
15, 2005. For additional information and
to obtain an application, visit the LAF Web site
at www.laf.org
or contact Daniela del Castillo, Associate Director
of Volunteer Services at (512) 236-8820 or daniela.delcastillo@laf.org.
NCI: Planning Grant for Minority Institution/Cancer
Center Collaboration
Letter of Intent: November
17, 2004
Application: December 17, 2004
The
National Cancer Institute invites planning grant
applications (P20s) to help researchers and faculty
at Minority-Serving Institutions (MSIs) in collaboration
with the researchers and faculty of NCI-designated
Cancer Centers (or other institutions with highly-organized,
integrated research efforts focused on cancer)
plan and implement focused collaborations in cancer
research, cancer research training, or cancer
education. The sole intent of this planning grant
is to provide support for cancer projects and
programs for a limited duration of time to perform
feasibility studies and obtain preliminary data
that will lead to the submission of specific competitive
grant applications traditionally supported by
the NCI and others.
MSIs
are defined as institutions at which students
of minority groups that are underrepresented in
the biomedical sciences (e.g., African Americans,
Hispanics, Native Americans, Alaskan Natives,
Native Hawaiians, Pacific Islanders), comprise
a significant proportion of the enrollments AND
at which there have been documented records of
commitment to the special encouragement of minority
faculty, students, and investigators.
For
more information visit RFA-CA-05-020
Inquiries:
Sanya A. Springfield Ph.D., springfs@mail.nih.gov;
Nelson Aguila D.V.M., aguilah@mail.nih.gov;
and Peter O. Ogunbiyi D.V.M., Ph. D., ogunbiyp@mail.nih.gov
NIH: Regional Translational
Research Center Planning Grants
Letter of Intent: December
1, 2004
Application: January 19, 2005
The
intent of this initiative is to create a new platform
that will aid translational scientists and advance
translational research. This RFA invites applications
for planning grants submitted by self-assembled
groups of institutions to conceptualize and design
Regional Translational Research Centers (RTRCs)
to foster more efficient and robust translational
research. Once operational, RTRCs will provide
a broad menu of clinical research expertise, services,
and core technologies to multiple institutions
within a region. The goal: to enhance the bi-directional—bench
to bedside and bedside to bench—communication
that characterizes translational research. Planning
grants to organize the content, administration,
and governance of three center models may be submitted:
(1) a regional center (RTRC) to provide clinical
research services that may include data/statistical/bioinformatics
support, assistance with regulatory issues and
communication with IRBs, recruitment cores, pilot
project support, and specialized staff as appropriate
; (2) a core technology center (C-RTRC) to offer
only core
technologies on a regional or national scale to
aid the study of disease pathogenesis or early-phase
clinical interventional studies; and (3) an expanded
center (E-RTRC), a hybrid of the first two models,
to provide regional clinical research services
plus core
technologies on a regional or national scale.
Future RFAs will request applications for the
actual RTRCs.
The
NIH Roadmap is providing $3 million for this initiative.
Individual planning grant awards may be up to
$150,000 in total costs for 1 year. An RFA to
solicit and fund planning grants for these centers
is now available at RFA-RM-008
(also see NOT-RM-05-001)
Should
you need clarification on this RFA, you are invited
to e-mail queries to nihrtrccomments@mail.nih.gov
and to participate in a live videoconference at
which a panel will answer questions from attendees.
This event is scheduled for November 10, 1:00-2:30
EST in Suite 401, 6707 Democracy Blvd., Bethesda,
Maryland. Please e-mail your questions before
the meeting to the appropriate contact:
1.
Scientific/Research Contact
Anthony
Hayward, M.D., Ph.D.
Director,
Division for Clinical Research Resources
National
Center for Research Resources
E-mail:
haywarda@mail.nih.gov
2.
Peer Review Contact
Martin
Goldrosen, Ph.D.
Director,
Office of Scientific Review
National
Center for Complementary and Alternative Medicine
E-mail:
goldrosm@mail.nih.gov
3.
Financial or Grants Management Contact
George
Tucker, M.B.A.
Grants
Management Officer, Office of Grants Management
National
Center for Complementary and Alternative Medicine
E-mail:
gt35v@nih.gov |
|
|
| AACI
Member Institutions Recruiting for Leadership Positions
Director
of Research Administration
The
Abramson Cancer Center of the University of Pennsylvania
The
Abramson Cancer Center of the University of Pennsylvania
in Philadelphia is actively recruiting for a director
of research administration. This position reports
to the executive director, Abramson Cancer Center.
The Abramson Cancer Center is one of the leading
NCI-designated comprehensive cancer centers, a
designation it has enjoyed for 30 years. The cancer
center is at the forefront of basic, translational,
clinical, and cancer control research with over
$170 million in cancer grants and 299 members.
This dynamic organization is undergoing a period
of growth and expansion. We have 11 NCI-approved
research programs led by nationally recognized
scientists leaders who are actively engaged in
facilitating intra- and inter-programmatic collaboration
and interaction, mentoring members, and stimulating
cancer grant activity. We have 10 long-standing
NCI-funded shared resources, and five additional
cores that have been established in recent years.
Usage and service mix are growing, and our advisory
committees are strong and engaged. Strategic planning
is a pinnacle philosophy of the Cancer Center
and guides our decisions and resource priorities.
The
director will be a senior member of a highly stable
administrative team composed of experienced individuals
who are highly regarded and have non-overlapping
areas of expertise/focus. The selected candidate
will play an active role in shaping and building
the research base and research administrative
structure of the Abramson Cancer Center. Specific
responsibilities will include: supporting research
divisions through program leader meetings, events,
and other relevant strategies; assisting program
leaders in fulfilling their programmatic responsibilities
and in achieving strategic goals; directing cancer
center communications aimed at providing relevant
information to scientists and building a sense
of "community"; active involvement in
planning and building shared resources; day to
day oversight of 15 shared resources; active participation
in strategic planning; managing databases and
other relevant information required by NCI; managing
a large pilot project program; facilitating strategies
to ensure compliance with NCI guidelines; and
active involvement in preparing NCI Core Grant
applications. Cancer center administration is
a highly collaborative, team-oriented and proactive
management group. The right candidate will be
a self-starter who brings three to five years
of relevant expertise, possesses good managerial
ability, high organizational capability, excellent
written and verbal skills, and a track record
in working effectively in a matrix environment.
Contact:
Beverly R. Ginsburg
Tel:
(215) 349-8382
Email:ginsburb@mail.med.upenn.edu
Executive Director
James
Graham Brown Cancer Center, University of Louisville
The
University of Louisville is currently searching
for an executive director for the James Graham
Brown Cancer Center. The Brown Cancer Center is
in a period of very rapid growth. The University
of Louisville, and the state of Kentucky have
invested over $60 million in the Brown Cancer
Center over the past five years. During
that period, more than 60 cancer scientists and
physicians have been recruited to the Cancer Center.
This has resulted in remarkable growth in research
programs and development of multidisciplinary
clinical programs. Brown Cancer Center is
currently in the third year of funding of its
P20 Cancer Center Planning Grant, and plans to
submit a P30 application in 2005.
Brown
is in the midst of an $8 million project to renovate
the clinical facilities of both the Cancer Center
and the University Hospital. Brown is also
establishing a statewide cancer network that will
enhance its clinical research capability, and
has just begun a $40.5 million fund raising campaign.
The
executive director will report directly to the
cancer center director and will have broad administrative
responsibility for both clinical and academic
portions of the Cancer Center’s programs.
The ideal candidate for this position will have
an MBA and five years of administrative experience
at an NCI-designated comprehensive cancer center
as well as both the interpersonal and managerial
skills required to help move the Brown Cancer
Center forward.
This
attractive position offers a competitive salary.
For
more information, please contact the office of
the director:
Donald
M. Miller, M.D., Ph.D.
Director,
James Graham Brown Cancer Center
University
of Louisville School of Medicine
Email:
donaldmi@ulh.org
Tel:
(502) 562-4790
Associate
Director for Scientific Administration
Louisiana Cancer Research Consortium in New Orleans
Tulane
University Health Sciences Center and Louisiana
State University Health Sciences Center in New
Orleans have joined together to develop the Louisiana
Cancer Research Consortium (LCRC) with the goal
of achieving NCI designation as a Comprehensive
Cancer Center. Planning is underway for a new
state-of-the-art cancer research building. The
Associate Director for Scientific Administration
(ADSA) will manage the development of Core resources
and maintain Cores according to NCI guidelines.
The ADSA will be responsible for the organization
and maintenance of the Office of Clinical Research
Core, establishing a mechanism for clinical research
protocol flow, including mechanisms for Institutional
Review Boards, Independent Safety Review Committees,
Data Safety Monitoring Boards and relevant accounting
systems. The ADSA will evaluate, acquire and implement
clinical informatics. The ADSA will coordinate
recruitment and ongoing management of faculty
and staff for the scientific mission of the LCRC.
The ADSA will coordinate scientist / architect
interaction, ensuring the scientists' needs and
wishes are clearly articulated to architects for
incorporation into their building plans. The ADSA
will report to the Directors of each cancer center
and will also interface with the Chief Financial
Office of the LCRC and with the Business Managers
from Tulane Cancer Center and the Stanley S. Scott
Cancer Center at LSUHSC. Advanced degree in business,
health administration or relevant field required.
Knowledge of and familiarity with center-wide
information systems and regulatory issues required.
Five years experience in health services administration
within an NCI designated cancer center preferred.
Personal involvement in P30 competitive renewal
or primary application preferred.
Qualified
candidates should forward CV and three letters
of reference to: Roy S.Weiner, M.D., Director,
Tulane Cancer Center, Tulane University Health
Sciences Center, 1430 Tulane Ave., SL-68, New
Orleans, LA 70112, directors@lacrc.net
or Oliver Sartor, M.D., Director, Stanley S. Scott
Cancer Center, Louisiana State University Health
Sciences Center, 533 Bolivar St., Room 4E1, New
Orleans, LA 70112, directors@lacrc.net.
|
|
|
|
